microRNAs as Promising Biomarkers of Platelet Activity in Antiplatelet Therapy Monitoring
We want to draw your attention to the latest review of TAmiRNA and the King’s College London, in Cardiovascular Diabetology.
“microRNAs as Promising Biomarkers of Platelet Activity in Antiplatelet Therapy Monitoring.” Krammer TL, Mayr M & Hackl M. Int. J. Mol. Sci.2020, 21(10), 3477; doi.org/10.3390/ijms21103477
In this review, we explain the secretion of miRNAs upon platelet activation and discuss the potential use of platelet-related miRNAs as biomarkers for CVD and antiplatelet therapy monitoring, but also highlight remaining gaps in our knowledge and uncertainties regarding clinical utility.